Properties
Description
Ubrogepant inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins.
Molecular Formula
C29H26F3N5O3
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Ubrogepant can be studied for its effect on blocking the CGRP receptors, which are involved in the transmission of pain signals during a migraine attack.
Storage
Store at -20°C, and keep desiccated.
